Dermatologic Therapy

Cover image for Vol. 30 Issue 3

Edited By: Michael D. Tharp

Impact Factor: 1.093

ISI Journal Citation Reports © Ranking: 2016: 50/63 (Dermatology)

Online ISSN: 1529-8019

Author Guidelines

Information for Authors

Dermatologic Therapy is a bimonthly online only journal. Each issue consists of a series of scholarly review articles focusing on either the treatment of a specific disease or the clinical application of a specific therapy or related group of therapeutic agents. The main purpose of this journal is to fill a void in the dermatologic literature in which experts describe very specifically how they treat a specific condition or use a particular medication. This information should be so practical that the reader can directly apply the information to clinical situations. Because of the specific and practical nature of the information contained in each issue, this publication could serve as an evolving therapeutic textbook for dermatology.


This journal now uses eLocators. For more information, please visit the Author Services eLocator page here.

Overview for Authors
-Author Services
-Author Material Archiving Policy
-NIH Funding and Questions
-English Language Editing Services

Author Services
For more details and a complete listing of services offered, and general information for journal authors, please visit the Author Services homepage.

Online production tracking is now available for your article through Wiley-Blackwell's Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online. Authors may check the status of their articles online and choose to receive automated e-mails at key stages of production so they don't need to contact the production editor to check on progress.

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS), they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected, the corresponding author will be presented with the copyright transfer agreement (CTA) to sign.

For terms and conditions of the CTA and Copyright FAQs, terms and conditions, please click here.

For authors choosing OnlineOpen

If the OnlineOpen option is selected, the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

• Creative Commons Attribution License OAA
• Creative Commons Attribution Non-Commercial License OAA
• Creative Commons Attribution Non-Commercial -NoDerivs License OAA

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements.

OnlineOpen is a service offered by Wiley that enables authors the opportunity to ensure that their final published contribution is made available for anyone to access online.

It is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article.

With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.

This option is an important part of Wiley's response to the calls for open access and our commitment to viable high-quality publishing on behalf of societies.

Any authors who wish to choose OnlineOpen will be required to complete the payment form.

OnlineOpen does not need to be indicated to the Editorial Office prior to acceptance. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

For further details, please visit the Author Services Online Open page.

Author Material Archive Policy
Please note that unless specifically requested, Wiley-Blackwell Publishing will dispose of all hardcopy or electronic material submitted two months after publication.

For more information on this policy and the Journal’s compliant self-archiving policy please visit here.

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement.

For any questions about this mandate, please visit our FAQ site.

English Language Editing Services
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission or during the review process. Authors wishing to pursue a professional English-language editing service should make contact and arrange payment with the editing service of their choice.

For more details regarding the recommended services, please visit Wiley Editing Services.

Please note, all services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.

Submission Requirements and Information

General Information for Submissions
Required Components
Manuscript Preparation
Manuscript Types and Details

General Information for Submissions

Simultaneous Submission
Manuscripts submitted to Dermatologic Therapy must not be under simultaneous consideration by any other publication and should not have been published elsewhere in substantially similar form. No part of the paper that has been published by Dermatologic Therapy may be reproduced or published elsewhere without the written permission of the author(s) and the Publisher.

The submission of the manuscript by the authors means that the authors automatically agree to assign exclusive copyright to John Wiley & Sons. The articles published in this journal are protected by copyright, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. As a result of the present U.S. copyright law, effective January 1, 1978, each contributor of a submitted manuscript must sign a statement expressly transferring copyright.

Informed Consent
The Journal requires that all appropriate steps be taken in obtaining informed consent of any subjects participating in the research comprising the manuscript submitted for review and possible publication. Each submission should contain a statement of appropriate institutional board approval and informed consent. For experimental investigations of human or animal subjects, state in the 'Methods' section that an appropriate institutional review board approved the project, and that informed consent was appropriately obtained. For those investigators who do not have formal ethics review committees (institutional or regional), the principles outlined in the Declaration of Helsinki should be followed and attested to.

Photographs with Identifiable Patients
The physical identification of a patient should be masked whenever possible. If a patient is identifiable, notice of informed consent and releases to publish photographs of recognizable persons should be submitted with the manuscript. Clearly state in the manuscript that informed consent has been obtained.

Disclosure Statement
A Conflict of interest disclosure from all authors is required. Conflicts of interest may fall under any of the following categories: Financial support, interests or commercial associations, or potential competing interests. These may include but are not limited to equity or stock ownership, payments for conducting or publicizing studies, or consultant arrangements. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to list during submission and on the title page of the manuscript all pertinent commercial and other relationships.

Authors' Professional and Ethical Responsibilities
Should possible scientific misconduct or dishonesty in research submitted for review be suspected or alleged, the Journal reserves the right to forward any submitted manuscript to the sponsoring or funding institution or to other appropriate authorities for investigation. The journal also screens manuscripts for incidents of plagiarism; please ensure that manuscripts present original data written in unique language.

Required Components

Title Page
All submissions must include a full title page within their main manuscript document. Title pages should include the following: the full manuscript title; each author's full name, their degrees (M.D., etc.), and their institutions; the full contact information of the corresponding author; keywords; a running short title; and Conflict of Interest statements for all authors (if an author has no conflict of interest relevant to the content of the submission, please state “no conflict of interest”).

Except for Letters to the Editor, all submissions must include their article Abstract, clearly labeled as such, preceding the Introduction section of the manuscript.

Figure Legends
Any submissions that include one or more supplementary figures should include a list of Figure Legends either within the manuscript document, or in a separate Word document.

For submissions that contain supplementary figures, patient photos, photomicrographs, and illustrations must be sharply focused, with excellent color balance and submitted as separately numbered TIFF or JPG files, of sufficient DPI and resolution to allow high resolution photographic print quality (300 DPI and 5 inches wide or greater). Photographs of less than 300x300 DPI (1500 pixels) and less than 5'' (125mm) in width will not be accepted. Papers submitted with photographs of unacceptable quality will not be considered.

More detailed information on the submission of electronic artwork can be found here.

Manuscript Preparation

Dermatologic Therapy only accepts electronic submissions using ScholarOne Manuscripts. Paper or email submissions will not be accepted.

To log into the site, please follow these instructions:
• Go to the journal’s online submission site at
• Log-in or click the “Create Account” option if you are a first-time user of ScholarOne Manuscripts.
• If you are creating a new account:
o After clicking on “Create Account”, enter your name and e-mail information and click “Next”. Your email information is very important.
o Enter your institution and address information as appropriate, and then click “Next.”
o Enter a user ID and password of your choice (we recommend using your e-mail address as your user ID), and then select your area of expertise. Click “Finish”.
• If you have an account but have forgotten your log in details, go to “Password Help” and enter your email address. The system will send you an automatic user ID and password reminder.
• Log-in and select “Author Center.”

To submit a manuscript, please follow these instructions:
• Once you have logged in and have entered your Author Center, click the “Submit a Manuscript” link in the menu bar. Enter data and answer questions as appropriate.
• Click the “Next” button on each screen to save your work and advance to the next screen.
• You are required to upload your files.
o Click on the “Browse” button and locate the file on your computer.
o Select the designation of each file in the drop down next to the Browse button.
o When you have selected all files you wish to upload, click the “Upload Files” button.
• Review your submission (in both PDF and HTML formats) before sending to the Journal. Click the “Submit” button when you are finished reviewing.
• You may suspend a submission at any phase before clicking the “Submit” button and save it to submit later. After submission, you will receive a confirmation e-mail. You can also access ScholarOne Manuscripts any time to check the status of your manuscript. The Journal will inform you by e-mail once a decision has been made.

If you need help throughout the submission process, the top of the screen has a ‘Get Help Now’ icon connecting directly to the online support system at Queries can also be e-mailed to and telephone support is available 24 hours a day, 5 days a week through the US ScholarOne support office on: +1 434 817 2040, ext 167. If you do not have Internet access or cannot submit online, please contact the editorial office.

Manuscript Types

Original contributions may be submitted for consideration in the following journal sections:

Review Article
These are intended to be concise up-to-date reviews which document and synthesize current information on a specific disease or treatment. Review articles should be no more than 5,000 words, a maximum of 3 tables and/or figures, and a maximum of 50 references.

Original Papers
Original papers should cover in depth, clinical and laboratory research. Papers should not exceed 3,000 words, a maximum of 3 tables and/or figures, and a maximum of 50 references.

Therapeutic Hotline
Authors submitting a paper to the Therapeutic Hotline will provide readers with key information on new therapies. The section will consist of one of two article formats:

Therapeutic Hotline: Letters should be no more than 600 words, a maximum of 3 tables and/or figures, and a maximum of 10 references

Therapeutic Hotline: Short Papers should be no more than 1,200 words, a maximum of 3 tables and/or figures, and a maximum of 15 references

Journal Highlights
Highlights should be no more than 300 words, with no tables or figures and a maximum of 15 references.

Resident Forum
The Resident Forum will consist of invited submissions. Articles should be no more than 1,200 words, a maximum of 3 tables and/or figures, and a maximum of 15 references.

Manuscript Details

List all sources in the reference list alphabetically by name. . In text citations should follow the author-date method. This means that the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998), and a complete reference should appear in the reference list at the end of the paper.

References are styled according to the sixth edition of the Publication Manual of the American Psychological Association. A sample of the most common entries in reference lists appears below. Please note that for journal articles, issue numbers are not included unless each issue in the volume begins with page one.

Journal article: Phelps, L. (1996). Discriminative validity of the WRAML with ADHD and LD children. Psychology in the Schools, 33, 5-12.

Book edition: Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: Infancy through high school (2nd ed.). Austin, TX: Pro-ed.

References should refer only to material listed within the text.

Use generic names wherever possible; capitalize trade names and include the manufacturer. For names of chemicals, a trivial name may be used if the formal chemical name is given with the first use of the trivial name. Abbreviations should be kept to a minimum. Use an appropriate abbreviation only if it appears at least five times in the text.